Correlation between antioxidant capacity and advanced glycation endproducts inhibition in enzyme-treated polysaccharides from Sargassum fusiforme
Food Science and Biotechnology · 2025-07 · 34 (11) · 2591-2600
DOI: 10.1007/s10068-025-01867-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Science and Biotechnology, online erschienen am 04.04.2025. Verfasst von Young Sung Jung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Food Functionality Research Division, Korea Food Research Institute, Wanju-Gun, 55365 Republic of Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Oceans and Fisheries, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Marine polysaccharides demonstrate strong antioxidant capacity and can effectively alleviate oxidative stress. However, their high molecular weight often makes them resistant to enzymatic breakdown in the digestive system, limiting their bioavailability, and functional effectiveness. This study explored the potential of enzyme-treated polysaccharides derived from Sargassum fusiforme (EPS) for antioxidant and anti-glycation applications and elucidated their potential in managing oxidative stress. Polysaccharide from S. fusiforme was enzyme-treated using α-amylase, cellulase, and α-amylase derived from Caco-2 cells. EPSs generated were analyzed for molecular weight distribution and residual metal ion content such as arsenic. EPSs exhibit enhanced antioxidant capacities and advanced glycation end-product (AGEs) inhibition, highlighting their potential in addressing oxidative stress and AGEs-related diseases. Correlation and principal component analysis revealed that molecular weight reduction positively influenced the antioxidant capacity and AGE-breaking activities. These findings suggest that EPSs could serve as a natural therapeutic agents in functional foods and nutraceuticals, offering a promising approach for mitigating oxidative stress-induced health issues. Supplementary Information: The online version contains supplementary material available at 10.1007/s10068-025-01867-2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Food Functionality Research Division, Korea Food Research Institute, Wanju-Gun, 55365 Republic of Korea.
- Department of Food Science and Biotechnology, Kyung Hee University, Yongin, 17104 Republic of Korea.
- Division of Food Biotechnology, University of Science and Technology, Daejeon, 34113 Republic of Korea.
- Department of Seafood Science and Technology, The Institute of Marine Industry, Gyeongsang National University, Jinju, Gyeongsangnam-Do 53064 Republic of Korea.
- Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, 34134 Republic of Korea.
ORCID-Profile: Sang-Hoon Lee
Förderung
- Ministry of Oceans and Fisheries
- Ministry of Science and ICT, South Korea
Zitieren
APA
Jung, Y. S., Cho, C. H., Kim, M., Kwon, T. Y., Choe, Y. R., Seo, N., Kim, H. S., An, H. J., & Lee, S. H. (2025). Correlation between antioxidant capacity and advanced glycation endproducts inhibition in enzyme-treated polysaccharides from Sargassum fusiforme. Food Science and Biotechnology, 34(11), 2591-2600. https://doi.org/10.1007/s10068-025-01867-2
Vancouver
Jung YS, Cho CH, Kim M, Kwon TY, Choe YR, Seo N, et al. Correlation between antioxidant capacity and advanced glycation endproducts inhibition in enzyme-treated polysaccharides from Sargassum fusiforme. Food Science and Biotechnology. 2025;34(11):2591-2600. doi:10.1007/s10068-025-01867-2
BibTeX
@article{Jung2025,
author = {Jung, Young Sung and Cho, Chi Heung and Kim, Mingyeong and Kwon, Tae Young and Choe, Yu Ri and Seo, Nari and Kim, Hyun-Soo and An, Hyun Joo and Lee, Sang-Hoon},
title = {Correlation between antioxidant capacity and advanced glycation endproducts inhibition in enzyme-treated polysaccharides from Sargassum fusiforme},
journal = {Food Science and Biotechnology},
year = {2025},
volume = {34},
number = {11},
pages = {2591--2600},
doi = {10.1007/s10068-025-01867-2}
}
EUVIMED